179 results found.
                
BARE BONES® - October 23, 2014
CONMED reported 3Q14 orthopaedic surgery product sales of US $92.8MM, -3.2% from 3Q13. Growth reflects constant currency. (CONM...
3Q14 Revenue: CONMED
$92.8MM, -3% U.S. SportsMed -9% due to reduced procedure-specific and resection sales, plus previous discontinuation of PRP products U.S. Powered Instruments +1% (Capital handpieces +6%, Single-use burrs and blades -3%) Edge ablation bipolar ra...
BARE BONES® - July 23, 2014
CONMED posted 2Q14 orthopaedic surgery product sales of US $102.4MM, +0.8% from 2Q13. (Growth reflects constant currency.) (
2Q14 Revenue: CONMED
$102.4MM, +0.8% Powered instrument handpieces +12% Shoulder repair devices +10% Sports tissue/biologic product sales decreased ~$1.3MM following contract supplier’s inability to supply platelet-rich plasma products for resale; will likely...
BARE BONES® - April 24, 2014
CONMED posted 1Q14 orthopaedic surgery product sales of US $105.9MM, +1.9% from 1Q13. (Growth reflects constant currency.) (
1Q14 Revenue: ConMed
$105.9MM, +2% Musculoskeletal Transplant Foundation (MTF)-related revenue -18% Powered Instruments +4% MTF revenue impacted by anticipated supplier inability to supply PRP devices for resale, may discontinue product Y-Knot Flex s...
BARE BONES® - April 16, 2014
CONMED is reportedly exploring the potential sale of the company. (Reuters, 4/15/14)
Arthroscopy/Soft Tissue Repair Market Exceeds $4.5 Billion
The arthroscopy and soft tissue repair market topped an estimated $4.5 billion in 2013, an increase of seven percent from 2012. The market is expected to experience high single-digit growth in each of the next five years, remaining among the healthier segments in the orthopaedic industry.
BARE BONES® - March 12, 2014
Arthroscopy and soft tissue repair product sales exceeded US $4.5BB in 2013, +7% from 2012, cites ORTHOWORLD in its newest market report. The segment is dominated by Arthrex, Smith & Nephew, DePuy Synthes, Stryker, CON...
BARE BONES® - February 13, 2014
CONMED reported 4Q13 orthopaedic surgery product sales of US $107.7MM, +2.2% from 4Q12, and 2013 sales of $410.2MM, +0.1% from 2012. (
4Q13/2013 Revenue: CONMED
4Q13 orthopaedic revenue: $107.7MM, +2% Sports Medicine/Tissue +3% Powered Instruments flat   2013 orthopaedic revenue: $410.2MM, +0.1% Healthcare utilization weaker than expected, hospital ...
AAOS Preview: Technologies and Partners to Discover in 2014
Updated 2/19/2015: As you prepare for AAOS 2015, review the below list of 2014 new and notable companies to see who made strategic moves in the industry. Of the 23 companies p...
BARE BONES® - October 24, 2013
CONMED reported 3Q13 orthopaedic surgery product sales of US $95.6MM, +0.8% from 3Q12. (
3Q13 Revenue: ConMed
Orthopaedic surgery products $95.6MM, +1% Procedure-specific and biologic products in sportsmed +8%, resection and fluid sportsmed products flat, powered instruments -5% Will preview a new 2-D system at AANA meeting, limited launch in 1Q14 Othe...
BARE BONES® - July 24, 2013
CONMED posted 2Q13 orthopaedic surgery product sales of US $101.8MM, -1.1% from 2Q12. (Growth reflects constant currency.) (CONMED Corporation, 7/24/13)
2Q13 Revenue: ConMed
Orthopaedic surgery product sales $101.8MM, -1% Sports Medicine -3% (Sports Biologics +4%) Powered Surgical -1%   Sports Med affected by foreign currency effects, government-imposed limits on procedures/spending in Euro...
BARE BONES® - July 9, 2013
Premier awarded new agreements for arthroscopy supplies to ConMed Linvatec, National Advanced Endoscopy Devices, Nexus Surgical, Smith & Nephew Endoscopy and Stryker Endoscopy. The agreements are available to ...
BARE BONES® - April 25, 2013
CONMED posted 1Q13 orthopaedic surgery product sales of US $105MM, -1.1% from 1Q12. (Growth reflects constant currency.) (...
1Q13 Revenue: ConMed
$105MM, -2% (Sports Medicine -3%, Powered Surgical +1%) Noted that healthcare utilization seems flat in the U.S., despite modest job growth Revenue growth impacted by reduction in international healthcare spending, specifically major European countries ...
The Orthobiologics Market
As defined by the American Academy of Orthopaedic Surgeons, orthobiologics are substances that orthopaedic surgeons use to help injuries heal more quickly. Orthobiologic products incorporate biology or biochemistry to repair, replace or regenerate musculoskeletal structures.  ...
BARE BONES® - February 14, 2013
CONMED posted 2012 orthopaedic sales of US $480.5MM, +10% vs. 2011, and 4Q12 sales of $124.9MM, +12% vs. 4Q11. (2012 Arthroscopy $330.5MM, +14%; Powered Surgical Instruments $150.0MM, ...
4Q12 and 2012 Revenue: ConMed
$480.5MM, +10% (MTF partnership revenue $28MM) Arthroscopy $330.5MM, +14% Powered Surgical Instruments $150.0MM, +1% 4Q12 revenue: $124.9MM, +12% (MTF partnership revenue $7MM) Arthroscopy $86.6MM, +16%
Merger and Acquisition Activity in 2012: Orthopaedics, Spine, Supplier
Merger and acquisition activity in 2012 was reduced in number of transactions vs. 2011. Year 2013 has already yielded four notable negotiations: the offer for Corin Group by 2IL Orthopaedics, the merger of BioMimetic Therapeutics with Wright Medical, DJO’s purchase of Exos and the acquis...
3Q12 Earnings: ConMed
$112.7MM, +8% (Musculoskeletal Transplant Foundation $6.2MM) Arthroscopy $76.6MM, +10% (Single-use products +12%) Powered Instruments $36.1MM, +4%
BARE BONES® - October 25, 2012
CONMED reported 3Q12 orthopaedic sales of US $112.7MM, +8% from 3Q11. (Arthroscopy $76.6MM, +12%; Powered Instruments $36.1MM, +5%) Overall growth is ORTHOWORLD estimate. (
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group